change in strategy sees this all the time. Old BOD want to stick with canine focus rather than shift to neurodegenerative diesease. FDA were satisfied enough with scientific data supporting sufficient promise. Also look at world renowned advisors who have jumped onboard.
the shakeout is not a bad thing IMO lets see the new hires this quarter. I am a flip of the coin may see DrT return.
.
change in strategy sees this all the time. Old BOD want to stick...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.025(13.5%) |
Mkt cap ! $83.14M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 22.0¢ | 20.0¢ | $733.4K | 3.538M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 113800 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 240088 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
0.025 ( 13.5 %) |
||||
| Open | High | Low | Volume | ||
| 20.5¢ | 22.0¢ | 20.0¢ | 1388603 | ||
| Last updated 15.56pm 31/05/2024 ? | |||||
| PAA (ASX) Chart |